ISIS PHARMACEUTICALS INC DEL's ticker is and the CUSIP is 464337AG9. A total of 19 filers reported holding ISIS PHARMACEUTICALS INC DEL in Q3 2014. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2016 | $99,377,000 | +48.2% | 44,441,000 | 0.0% | 1.48% | +45.8% |
Q2 2016 | $67,060,000 | -23.5% | 44,441,000 | +25.4% | 1.02% | -59.2% |
Q1 2016 | $87,701,000 | -33.7% | 35,441,000 | 0.0% | 2.49% | -12.5% |
Q4 2015 | $132,261,000 | +59.6% | 35,441,000 | +4.9% | 2.85% | +45.7% |
Q3 2015 | $82,871,000 | -20.0% | 33,790,000 | +12.8% | 1.96% | -16.8% |
Q2 2015 | $103,634,000 | +12.2% | 29,959,000 | +24.7% | 2.35% | +27.6% |
Q1 2015 | $92,390,000 | +115.1% | 24,016,000 | +107.6% | 1.84% | +120.3% |
Q4 2014 | $42,944,000 | -31.1% | 11,570,000 | -55.0% | 0.84% | -35.7% |
Q3 2014 | $62,292,000 | +11.0% | 25,720,000 | +0.9% | 1.30% | +5.8% |
Q2 2014 | $56,108,000 | +4.3% | 25,500,000 | +27.5% | 1.23% | +6.8% |
Q1 2014 | $53,777,000 | +8.0% | 20,000,000 | 0.0% | 1.15% | +16.9% |
Q4 2013 | $49,772,000 | +6.3% | 20,000,000 | 0.0% | 0.98% | -5.5% |
Q3 2013 | $46,823,000 | – | 20,000,000 | – | 1.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|